Turnstone Biologics Corp.
TSBX
$0.35
$0.0319.72%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -69.48% | -58.50% | 26.73% | 21.69% | 15.50% |
| Total Receivables | -- | -- | -- | -- | -97.78% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -31.45% | -45.05% | -20.03% | -33.92% | -8.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -28.18% | -22.15% | 11.39% | 2,136.21% | 37.40% |
| Total Current Assets | -66.63% | -56.96% | 21.87% | 12.65% | 4.65% |
|
|
|||||
| Total Current Assets | -66.63% | -56.96% | 21.87% | 12.65% | 4.65% |
| Net Property, Plant & Equipment | -43.98% | -42.63% | -42.83% | -40.85% | -36.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -29.05% | -27.43% | -81.43% | -60.24% | -55.73% |
| Total Assets | -64.42% | -55.46% | 2.82% | 2.31% | -1.85% |
|
|
|||||
| Total Accounts Payable | 2,316.67% | -76.50% | 650.51% | 68.60% | -98.95% |
| Total Accrued Expenses | -36.99% | 35.76% | -13.15% | -11.76% | -3.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -46.42% | -27.67% | -10.31% | 2.27% | 3.26% |
| Total Finance Division Other Current Liabilities | -- | -- | -96.66% | -97.88% | -- |
| Total Other Current Liabilities | -- | -- | -96.66% | -97.88% | -- |
| Total Current Liabilities | -31.50% | 4.30% | -16.24% | -17.92% | -65.63% |
|
|
|||||
| Total Current Liabilities | -31.50% | 4.30% | -16.24% | -17.92% | -65.63% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -91.25% | -84.66% | -81.39% | -74.53% | -62.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -62.69% | -64.45% | -56.47% | -56.62% | -84.62% |
| Total Liabilities | -38.71% | -14.76% | -26.73% | -29.93% | -68.18% |
|
|
|||||
| Common Stock & APIC | 1.35% | 1.50% | 1,127.63% | 1,183.15% | 1,243.85% |
| Retained Earnings | -40.08% | -46.42% | -52.24% | -61.65% | -45.41% |
| Treasury Stock & Other | -69.75% | 18.67% | 3.00% | 19.18% | 71.19% |
| Total Common Equity | -68.11% | -61.68% | 149.53% | 179.83% | 197.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -68.11% | -61.68% | 149.53% | 179.83% | 197.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -68.11% | -61.68% | 16.27% | 11.53% | 40.00% |
|
|
|||||